| OCTiMS |
NCT02907281 |
A 3-years, multi-center study to evaluate optical choherence tomography as an outcome measure in patients with multiple sclerosis |
| VIVID-DME |
NCT01331681 |
Intravitreal Aflibercept Injection in Vision Impairment Due to DME |
| CRYSTAL |
NCT01535261 |
Ranibizumab Intravitreal Injections in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion |
| BRIGHTER |
NCT01599650 |
Efficacy and Safety of Ranibizumab With or Without Laser in Comparison to Laser in Branch Retinal Vein Occlusion |
| OCTAVE |
NCT01780935 |
Efficacy and Safety of Two Treatment Regimens of 0.5 mg Ranibizumab Intravitreal Injections Guided by Functional and/or Anatomical Criteria, in Patients With Neovascular Age-related Macular Degeneration |
| TREND |
NCT01948830 |
Randomized Study for Efficacy and Safety of Ranibizumab 0.5mg in Treat-extend and Monthly Regimens in Patients With nAMD |
| HARRIER |
NCT02434328 |
Efficacy and Safety of RTH258 Versus Aflibercept - Study 2 |
| ALCON JETREA |
NCT02035748 |
Assessment of Patients Treated With JETREA® for Vitreomacular Traction |
| RAINBOW |
NCT02375971 |
RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity |
| YOSEMITE |
NCT03622580 |
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema |
| RHINE |
NCT03622593 |
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema |
| TENAYA |
NCT03823287 |
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration |
| LUCERNE |
NCT03823300 |
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration |
| KODIAK KSI-CL-102 |
NCT04049266 |
A Phase 2b/3, Prospective, Randomised, Double-masked, Active Comparator-controlled, Multi-center Study to Investigate the Efficacy and Safety of Repeated Intravitreal Administration of KSI-301 in Subjects with Neovascular (Wet) Age-related Macular Degeneration (DAZZLE) |
| TALON |
NCT04005352 |
Study to Assess the Efficacy and Safety of Brolucizumab 6mg Compared to Aflibercept 2 mg in a Treat-to-control Regimen |
| OCTOPUS |
NCT04239027 |
A Study to Assess the Effects of Brolucizumab in Adult Patients With Neovascular Age Related Macular Degeneration |
| BALATON |
NCT04740905 |
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein Occlusion |
| COMINO |
NCT04740931 |
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion |
| RHONE-X |
NCT04432831 |
A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Diabetic Macular Edema |
| GLEAM |
NCT04611152 |
A Trial to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME) |
| GLIMMER |
NCT04603937 |
A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME) |
| BEACON |
NCT02087085 |
A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration |
| GLOW |
NCT05066230 |
NCT05066230 A Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 in Non-proliferative Diabetic Retinopathy (NPDR) |
| AVONELLE-X |
NCT04777201 |
A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration |
| DAYLIGHT |
NCT04964089 |
A Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 Compared With Intravitreal Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) |